drugset / Trial / NCT00059462
Safety and Efficacy of BAY 50-4798 in Patients With HIV Infection
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety of the experimental drug Bay 50-4798 in HIV positive patients receiving HAART and to test the drug's effect on the CD4+ T-cell count.
Timeline
- Start
- 2002-12
- Primary completion
- 2005-03
- Completion
- 2005-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bay 50-4798 | Unknown | — | Subcutaneous |